Fusion will be attending the European Cancer Cluster Partnering event, Oslo, Norway on the 15th -17th September 2010
Fusion Antibodies has recently created a new division Fusion Therapeutics which cover all of our research and development projects. As a result all information relating to our pipeline of oncology taregets can be found at http://www.fusiontherapeutics.com